Partners Group Holding’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,082
Closed -$849K 73
2022
Q4
$849K Sell
2,082
-240
-10% -$93.2K 0.06% 46
2022
Q3
$757K Buy
2,322
+1,154
+99% +$424K 0.05% 53
2022
Q2
$410K Buy
1,168
+251
+27% +$102K 0.02% 79
2022
Q1
$502K Buy
917
+220
+32% +$116K 0.03% 83
2021
Q4
$459K Hold
697
0.02% 90
2021
Q3
$433K Buy
+697
New +$468K 0.03% 121

Other funds holding IDXX

Partners Group Holding's IDXX Position: Q1 2023 in Review

Partners Group Holding sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 2,082 shares — an estimated $849K sold.

Partners Group Holding first reported a position in IDXX in Q3 2021 and held it in 6 quarters. The position peaked at $849K in Q4 2022. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Partners Group Holding reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Partners Group Holding sold 2,082 Idexx Laboratories shares in Q1 2023, an estimated $849K.
  • Partners Group Holding first reported a position in Idexx Laboratories in Q3 2021 and held it in 6 quarters.
  • Partners Group Holding's Idexx Laboratories position peaked at $849K in Q4 2022.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Partners Group Holding's 13F filing for Q1 2023, filed 5 May 2023.